OKYO Pharma Limited logo

OKYO Pharma Limited

NASDAQ:OKYO

Overview | Financials
Company Name OKYO Pharma Limited
Symbol OKYO
Currency USD
Price 1.44
Market Cap 48,193,465
Dividend Yield 0%
52-week-range 0.92 - 3.07
Industry Biotechnology
Sector Healthcare
CEO Dr. Gary S. Jacob Ph.D.
Website https://www.okyopharma.com

An error occurred while fetching data.

About OKYO Pharma Limited

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue

Related Stocks

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

BeyondSpring Inc. logo

BeyondSpring Inc.

BYSI

2.76 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

2.4 USD

Sera Prognostics, Inc. logo

Sera Prognostics, Inc.

SERA

9.57 USD

NexImmune, Inc. logo

NexImmune, Inc.

NEXI

3.11 USD

MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc.

INKT

0.969 USD

Financials

Numbers are in millions USD

Numbers are in millions USD